Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $25.63M | $33.45M | -23.37% |
Operating Income | $-366.25M | $-315.53M | -16.07% |
Net Income | $-324.29M | $-286.39M | -13.23% |
EPS (Basic) | $-3.32 | $-3.49 | +4.87% |
EPS (Diluted) | $-3.32 | $-3.49 | +4.87% |
R&D Expense | $310.34M | $266.12M | +16.62% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.31B | $1.17B | +11.93% |
Current Assets | $1.1B | $945.53M | +16.18% |
Total Liabilities | $345.08M | $380.05M | -9.20% |
Current Liabilities | $182.56M | $166.24M | +9.81% |
Stockholders' Equity | $966M | $791.32M | +22.08% |
Cash & Equivalents | $267.96M | $230.2M | +16.40% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-261.81M | $-270.88M | +3.35% |
Investing Cash Flow | $-229.84M | $58.73M | -491.38% |
Financing Cash Flow | $476.16M | $4.29M | +10994.20% |
D&A | $16.63M | $16.48M | +0.87% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1428.8% | -943.3% | -485.50% |
Net Margin | -1265.1% | — | — |
ROE | -33.6% | — | — |
ROA | -24.7% | — | — |
Current Ratio | $6.017 | — | — |
Debt to Equity | $0.357 | — | — |
Other companies in Biotechnology